REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY
KIBRA 在 HIPPO 信号通路中的调节和功能
基本信息
- 批准号:8360441
- 负责人:
- 金额:$ 27.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectCellsCentrosomeChromosomesDrosophila genusFundingGrantHalf-LifeHumanMammalian CellMicrotubulesMitosisMusNational Center for Research ResourcesNebraskaPhosphorylationPhosphotransferasesPrincipal InvestigatorProteinsRNA InterferenceRegulationResearchResearch InfrastructureResourcesSignal PathwaySignal TransductionSourceStructureTransfectionUnited States National Institutes of Healthcosthuman STK6 protein
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
KIBRA is a new component of the Hippo signaling pathway in Drosophila. Mechanisms by which KIBRA affects Hippo signaling and the function of KIBRA in mammalian cells are not clear.
We demonstrated that KIBRA associates with and activates Lats1and Lats2. In addition, we showed that transfection of RNAi specific for KIBRA decreases and over-expression of KIBRA increases the cellular level of phosphorylated YAP, which is the downstream substrate/target of the Lats1/2 kinases. Interestingly, we found that KIBRA stabilizes Lats2 by inhibiting the ubiquitylation of Lats2. KIBRA prolongs the half-life of Lats2. KIBRA itself is a transcriptional target of the Hippo signaling pathway both in mouse and human cells.
KIBRA promotes phosphorylation of S83 on Lats2, which is dependent on Aur-A kinase. Over-expression of KIBRA strongly stimulates Aur-A kinase activity revealed by Aur-A auto-phosphorylation level (p-T288). Furthermore, we were able to detect the interaction between Aur-A and KIBRA when these two proteins were co-transfected in 293T cells. We found that KIBRA is a phospho-protein, the phospho-level of KIBRA peaks at the G2/M phase. RNAi-knockdown of KIBRA disrupts the microtubule structure and affects the Aurora-A and Lats2 localization. KIBRA also controls centrosome maturation and chromosome alignment.
这个子项目是利用这些资源的众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jixin Dong其他文献
Jixin Dong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jixin Dong', 18)}}的其他基金
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
靶向 MARK2-HDAC 信号传导以克服胰腺癌中的紫杉醇耐药性
- 批准号:
10518249 - 财政年份:2022
- 资助金额:
$ 27.19万 - 项目类别:
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
靶向 MARK2-HDAC 信号传导以克服胰腺癌中的紫杉醇耐药性
- 批准号:
10707545 - 财政年份:2022
- 资助金额:
$ 27.19万 - 项目类别:
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
靶向 PKR-Bcl2 信号传导以克服卵巢癌中的紫杉醇耐药性
- 批准号:
10502982 - 财政年份:2022
- 资助金额:
$ 27.19万 - 项目类别:
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
靶向 PKR-Bcl2 信号传导以克服卵巢癌中的紫杉醇耐药性
- 批准号:
10672464 - 财政年份:2022
- 资助金额:
$ 27.19万 - 项目类别:
Regulation and Functional Dissection of YAP in Mitosis
YAP 在有丝分裂中的调控和功能解析
- 批准号:
8614249 - 财政年份:2014
- 资助金额:
$ 27.19万 - 项目类别:
Regulation and Functional Dissection of YAP in Mitosis
YAP 在有丝分裂中的调控和功能解析
- 批准号:
8790759 - 财政年份:2014
- 资助金额:
$ 27.19万 - 项目类别:
REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY
KIBRA 在 HIPPO 信号通路中的调节和功能
- 批准号:
8168390 - 财政年份:2010
- 资助金额:
$ 27.19万 - 项目类别:
相似国自然基金
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
- 批准号:82070825
- 批准年份:2020
- 资助金额:53 万元
- 项目类别:面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
- 批准号:81903002
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
- 批准号:81402419
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
- 批准号:81271563
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
- 批准号:31271248
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
- 批准号:81160050
- 批准年份:2011
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
相似海外基金
The Centrosome as a Compass for Asymmetric Cells
中心体作为不对称细胞的指南针
- 批准号:
RGPIN-2020-05187 - 财政年份:2022
- 资助金额:
$ 27.19万 - 项目类别:
Discovery Grants Program - Individual
The Centrosome as a Compass for Asymmetric Cells
中心体作为不对称细胞的指南针
- 批准号:
RGPIN-2020-05187 - 财政年份:2021
- 资助金额:
$ 27.19万 - 项目类别:
Discovery Grants Program - Individual
Establishment of stable somatic haploid cells through engineering of centrosome duplication "checkpoint"
通过中心体复制“检查点”工程建立稳定的体细胞单倍体细胞
- 批准号:
21K19244 - 财政年份:2021
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The Centrosome as a Compass for Asymmetric Cells
中心体作为不对称细胞的指南针
- 批准号:
RGPIN-2020-05187 - 财政年份:2020
- 资助金额:
$ 27.19万 - 项目类别:
Discovery Grants Program - Individual
Principle of chronic centrosome aberrations in whole-genome duplicated cells and its contribution to cellular heterogeneity
全基因组复制细胞慢性中心体畸变的原理及其对细胞异质性的贡献
- 批准号:
19H03219 - 财政年份:2019
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Understanding of molecular machineries that ensure mitotic spindle bipolarity in human cells independently of centrosome number
了解确保人体细胞有丝分裂纺锤体双极性的分子机制,与中心体数量无关
- 批准号:
18K14705 - 财政年份:2018
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Centrosome-cilium biogenesis and function in human cells.
人类细胞中的中心体纤毛生物发生和功能。
- 批准号:
390435 - 财政年份:2018
- 资助金额:
$ 27.19万 - 项目类别:
Operating Grants
Physics of Centrosome Reorientation during Signaling Activation in Immune Cells
免疫细胞信号激活过程中中心体重新定向的物理学
- 批准号:
1607645 - 财政年份:2016
- 资助金额:
$ 27.19万 - 项目类别:
Continuing Grant
Centrosome related gene introduced dendritic cells (DC), with functional modification of DC, show cytotoxic activity.
引入中心体相关基因的树突状细胞(DC),对DC进行功能修饰,表现出细胞毒活性。
- 批准号:
26462425 - 财政年份:2014
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Microirradiation system for centrosome in human-derived living cells
人源活细胞中心体微辐射系统
- 批准号:
22740269 - 财政年份:2010
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Young Scientists (B)